Atlas Trials

Comparison Between XELOX and S1, Oxaliplatin and Docetaxel as Neoadjuvant Chemotherapy for Gastric Cancer

Clinical trial NCT02623153 · UNKNOWN

Trial details

NCT number
NCT02623153
Sponsor
Tianshu Liu
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2016-01-01
Primary completion
2017-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.